Life360, Inc. director John Philip Coghlan reported that the John Coghlan Living Trust sold 4,000 shares of common stock on November 2, 2026: 1,841 shares at a weighted average of $45.29, 1,433 at $46.00, and 726 at $46.69. The sales were made under a Rule 10b5-1 trading plan adopted December 8, 2025. After the transactions, Coghlan reported 5,676 shares held directly, including 3,630 restricted stock units, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust.
Life360, Inc. (LIF) is the issuer whose ordinary shares AustralianSuper Pty Ltd reports beneficially owning: 6,466,182 shares, or 7.94% of the class.
Life360, Inc. director Charles J. Prober exercised options for 7,930 shares of common stock at an exercise price of $11.18 per share on October 13, 2026, then sold 7,930 shares at $43.29 per share. The reported transactions were made under a Rule 10b5-1 trading plan adopted March 14, 2025; the plan is written and pre-established and provides for automatic sales under predetermined criteria.
Life360, Inc. director Charles J. Prober reported a proposed sale of 7,930 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $343,289.70 and an approximate sale date of October 13, 2026. The notice lists the shares as acquired from the issuer through a stock option exercise on October 13, 2026, with cash payment.
Life360, Inc. director Alex Haro exercised options for 50,000 common shares at $2.53 per share on October 6, 2026. The derivative entry listed 145,565 shares following the transaction. On the same date, he sold 48,608 shares at a weighted average of $41.41 (range $41.137–$42.135) and 1,392 shares at a weighted average of $42.36 (range $42.145–$42.74). The reported transactions were effected pursuant to a written, pre-established Rule 10b5-1 trading plan adopted June 9, 2026.
Life360, Inc. (LIF) lists a proposed sale by director Alexander Haro of 50,000 common shares, with an approximate sale date of October 6, 2026, and an aggregate market value of $2,072,045.58; NASDAQ is listed as the exchange. The shares are identified as acquired through a stock option exercise on October 6, 2026, with cash payment. The notice also reports that Alexander Haro sold 50,000 common shares on September 21, 2026, for gross proceeds of $2,044,285.00.
Life360, Inc. (LIF) ownership disclosure was amended by Paradice Investment Management Pty Ltd, which reported beneficial ownership of 3,612,414 common shares, equal to 4.44% of the class, as of September 30, 2026. The report identifies the position as 5% or less of the class.
For Life360, Inc., director John Philip Coghlan reported that the John Coghlan Living Trust sold 3,800 common shares at a weighted-average price of $40.34 per share and 200 shares at a weighted-average price of $40.97 per share on October 1, 2026. Both sales were made under a Rule 10b5-1 trading plan adopted by Coghlan on December 8, 2025.
Life360, Inc. (LIF) director John Philip Coghlan reported a proposed sale of 12,000 common shares with an aggregate market value of $489,791. The shares are listed as acquired through private purchases. The notice also reports two prior sales during the preceding three months: 4,000 shares on August 3, 2026, for $219,259 and 4,000 shares on September 1, 2026, for $167,878.
Life360, Inc. director Alex Haro exercised options for 50,000 common shares on September 21, 2026, at $2.53 per share. That day, Haro sold 31,275 shares at a weighted-average $40.72 per share and 18,725 shares at a weighted-average $41.16 per share. The transactions were effected under a Rule 10b5-1 trading plan adopted June 9, 2026. The option position covered 195,565 shares following the exercise.